Skip to main content
. 2021 Oct 5;11:19712. doi: 10.1038/s41598-021-99311-y

Figure 3.

Figure 3

Kaplan–Meier curves for progression-free survival and overall survival in patients with NSCLC (a,c) and patients with melanoma (b,d) stratified by soluble programmed death ligand 1 levels. NSCLC non-small cell lung cancer, ΔsPD-L1 change in sPD-L1 concentration between pretreatment and posttreatment sampling, PFS progression-free survival, OS overall survival.